Journal
PSYCHIATRY RESEARCH
Volume 229, Issue 1-2, Pages 586-588Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.psychres.2015.07.054
Keywords
Pharmacogenomics; Pharmacogenetics; Clozapine
Categories
Funding
- CAPES/PROEX
Ask authors/readers for more resources
Previous association results between dopamine D1 receptor (DRD1) rs4532 polymorphism and antipsychotic treatment response in schizophrenia and schizoaffective subjects have been conflicting. Thus, we have conducted a systematic review followed by a meta-analysis. Our results indicated no association between DRD1 rs4532 polymorphism and overall antipsychotic response or clozapine monotherapy response. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
